Life Sciences & Healthcare M&A

Medical Device and Biotech M&A

Orion Capital Group has unique experience in selling medical device and biotech companies.  Many of our principals have industry experience resulting in a smoother negotiating process and a greater possibility of reaching strategic buyers.

The medical device and biotech sector includes devices & diagnostics, pharma & biotech and laboratory businesses. The M&A process in this sector requires specialized knowledge in order reach correct valuations. 

Strategy and valuation in this industry is probably the most crucial because valuations hinge on a number of factors that are non-existent in other sectors.  For example, FDA considerations, Stark laws, GPO contracts and intellectual property considerations are important factors to consider to in finding the right strategic buyer.   Additionally, the sales process must take into account:

• long regulatory cycles
• the market dominance and distribution channels of the big pharmaceutical companies
• the great amount of innovation
• the fact that most small to medium companies have only one product and may be undervalued

Understanding these unique features is necessary to understand how your potential buyers view your value and how to use that knowledge to obtain the highest price for your company. Orion Capital Group has the depth of knowledge necessary, and commonly engages engineers, doctors, and scientists to look beyond the numbers to find hidden value.